124 related articles for article (PubMed ID: 16331809)
1. [Expression of Fas and FasL in serum and placenta of preeclamptic pregnancy and its significance].
Hu WS; Wang ZP; Dong MY; Wang HZ
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2005 Nov; 34(6):499-502. PubMed ID: 16331809
[TBL] [Abstract][Full Text] [Related]
2. Fas and FasL expression in placentas complicated with intrauterine growth retardation with and without preeclampsia.
Rešić Karara J; Zekić Tomas S; Marušić J; Roje D; Kuzmić Prusac I
J Matern Fetal Neonatal Med; 2016; 29(7):1154-9. PubMed ID: 25909501
[TBL] [Abstract][Full Text] [Related]
3. [Correlation of the expressions of advanced glycation end products and its receptor in serum and placenta with the pathogenesis of preeclampsia].
Xian N; Chen W; Zhang Y; Li J; Zhang N; Ye Y
Zhonghua Fu Chan Ke Za Zhi; 2015 Jul; 50(7):493-9. PubMed ID: 26311638
[TBL] [Abstract][Full Text] [Related]
4. [Expression of Fas antigen and ligand, placental growth factor in placenta of pregnant women with pre-eclampsia].
Yue XY; Zhang X; Cui SH; Wang XQ
Zhonghua Fu Chan Ke Za Zhi; 2005 May; 40(5):320-2. PubMed ID: 15938782
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of soluble concentration Fas and Fas ligand in maternal and cord blood 3rd trimester of pregnancy.
Karowicz-Bilińska A; Kowalska-Koprek U; Estemberg D; Sikora-Szubert A
Ginekol Pol; 2018; 89(3):142-146. PubMed ID: 29664549
[TBL] [Abstract][Full Text] [Related]
6. Serum levels of soluble Fas and Fas ligand in pregnant women who smoke.
Hasan S; Alshaikh B; Yusuf K
Am J Reprod Immunol; 2021 Jun; 85(6):e13382. PubMed ID: 33247994
[TBL] [Abstract][Full Text] [Related]
7. Serum soluble Fas levels in preeclampsia.
Hsu CD; Harirah H; Basherra H; Mor G
Obstet Gynecol; 2001 Apr; 97(4):530-2. PubMed ID: 11275023
[TBL] [Abstract][Full Text] [Related]
8. Dysregulation of the Fas/FasL system in an experimental animal model of HELLP syndrome.
Gibbens J; Morris R; Bowles T; Spencer SK; Wallace K
Pregnancy Hypertens; 2017 Apr; 8():26-30. PubMed ID: 28501275
[TBL] [Abstract][Full Text] [Related]
9. Associations of serum soluble Fas and Fas ligand (FasL) with outcomes in systemic lupus erythematosus.
Vincent FB; Kandane-Rathnayake R; Koelmeyer R; Harris J; Hoi AY; Mackay F; Morand EF
Lupus Sci Med; 2020 Jun; 7(1):. PubMed ID: 32546562
[TBL] [Abstract][Full Text] [Related]
10. Serum Fas/FasL levels in dependence on clinical presentations of coronary disease and their relationship with risk factors.
Ristić T; Djordjević VB; Deljanin-Ilić M; Cosić V; Kundalić S
Vojnosanit Pregl; 2010 Jul; 67(7):537-42. PubMed ID: 20707047
[TBL] [Abstract][Full Text] [Related]
11. [Relationships between concentrations of free fatty acid in serum and oxidative-damage levels in placental mitochondria and preeclampsia].
Yan JY; Xu X
Zhonghua Fu Chan Ke Za Zhi; 2012 Jun; 47(6):412-7. PubMed ID: 22932105
[TBL] [Abstract][Full Text] [Related]
12. Fetal growth restriction is associated with reduced FasL expression by decidual cells.
Eide IP; Isaksen CV; Salvesen KA; Langaas M; Günther CC; Iversen AC; Austgulen R
J Reprod Immunol; 2007 Jun; 74(1-2):7-14. PubMed ID: 17196256
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of HBxAg in hepatocellular carcinoma and its relationship with Fas/FasL system.
Wang XZ; Chen XC; Chen YX; Zhang LJ; Li D; Chen FL; Chen ZX; Chen HY; Tao QM
World J Gastroenterol; 2003 Dec; 9(12):2671-5. PubMed ID: 14669310
[TBL] [Abstract][Full Text] [Related]
14. Fas ligand neutralization attenuates hypertension, endothelin-1, and placental inflammation in an animal model of HELLP syndrome.
Gibbens J; Spencer SK; Solis L; Bowles T; Kyle PB; Szczepanski JL; Dumas JP; Robinson R; Wallace K
Am J Physiol Regul Integr Comp Physiol; 2020 Aug; 319(2):R195-R202. PubMed ID: 32640833
[TBL] [Abstract][Full Text] [Related]
15. Placental productions and expressions of soluble endoglin, soluble fms-like tyrosine kinase receptor-1, and placental growth factor in normal and preeclamptic pregnancies.
Gu Y; Lewis DF; Wang Y
J Clin Endocrinol Metab; 2008 Jan; 93(1):260-6. PubMed ID: 17956952
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis and expression of Bcl-2, Bax, p53, caspase-3, and Fas, Fas ligand in placentas complicated by preeclampsia.
Mendilcioglu I; Karaveli S; Erdogan G; Simsek M; Taskin O; Ozekinci M
Clin Exp Obstet Gynecol; 2011; 38(1):38-42. PubMed ID: 21485723
[TBL] [Abstract][Full Text] [Related]
17. Soluble Fas ligand is associated with natural killer cell dynamics in coronary artery disease.
Szymanowski A; Li W; Lundberg A; Evaldsson C; Nilsson L; Backteman K; Ernerudh J; Jonasson L
Atherosclerosis; 2014 Apr; 233(2):616-622. PubMed ID: 24534457
[TBL] [Abstract][Full Text] [Related]
18. FAS A-670G and Fas ligand IVS2nt A 124G polymorphisms are significantly increased in women with pre-eclampsia and may contribute to HELLP syndrome: a case-controlled study.
Raguema N; Zitouni H; Ben Ali Gannoun M; Benletaifa D; Almawi WY; Mahjoub T; Lavoie JL
BJOG; 2018 Dec; 125(13):1758-1764. PubMed ID: 30066360
[TBL] [Abstract][Full Text] [Related]
19. Inhibiting trophoblast PAR-1 overexpression suppresses sFlt-1-induced anti-angiogenesis and abnormal vascular remodeling: a possible therapeutic approach for preeclampsia.
Zhao Y; Zheng Y; Liu X; Luo Q; Wu D; Liu X; Zou L
Mol Hum Reprod; 2018 Mar; 24(3):158-169. PubMed ID: 29325127
[TBL] [Abstract][Full Text] [Related]
20. [Relationship between serum and placental interleukin-18 levels and preeclampsia].
Huang XD; Huang HF; Dong MY; Yao QW; Wang HZ
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2005 Nov; 34(6):495-8. PubMed ID: 16331808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
